INTRODUCTION: The usefulness of peripheral femoral nerve block for pain management after hip fracture has been established. This prospective and randomised study compared the analgesia effect of a continuous femoral nerve block (CF) versus two conventional analgesia proceduresafter hip fracture. PATIENTS AND METHODS: Patients. (n=62) scheduled for surgery under spinal anaesthesia were prospectively included. After surgery, analgesia (48 hours) was randomised: group FC (femoral catheter, anterior paravascular approach, initial bolus followed by continuous infusion of ropivacaine 0.2%), group P (iv 2 g propacetamol/6 hours), group M (sc morphine, 0.05 mg/kg per 4 hour). Intravenous morphine titration was performed, followed by subcutaneous (sc) morphine every 4 hours according to the VAS score. The primary end-point was the morphine requirements. Secondary end-points were VAS score, side effects, and mortality. RESULTS:Demographic data and surgical procedures were similar between groups. After morphine titration, the VAS pain score did not differ between groups. All patients in-group M received additional morphine. Morphine mean consumption was increased in CF group: 26 mg (5-42) versus P: 8 mg (3-12) (p=0.0001) or M: 19 mg (8-33) (p<0.006) while constipation was decreased in P group vs CF. Percentage of patients requiring no morphine was similar between P (n=6; 28%) and CF (n=6; 28%) and greater than M (n=0; 0%). Hospital discharge, cardiovascular or pulmonary complications and mortality after 6 months showed no statistical difference. CONCLUSION:Continuous femoral nerve block provided limited pain relief after hip fracture did not reduced side effects and induced an expensive cost.
RCT Entities:
INTRODUCTION: The usefulness of peripheral femoral nerve block for pain management after hip fracture has been established. This prospective and randomised study compared the analgesia effect of a continuous femoral nerve block (CF) versus two conventional analgesia procedures after hip fracture. PATIENTS AND METHODS: Patients. (n=62) scheduled for surgery under spinal anaesthesia were prospectively included. After surgery, analgesia (48 hours) was randomised: group FC (femoral catheter, anterior paravascular approach, initial bolus followed by continuous infusion of ropivacaine 0.2%), group P (iv 2 g propacetamol/6 hours), group M (sc morphine, 0.05 mg/kg per 4 hour). Intravenous morphine titration was performed, followed by subcutaneous (sc) morphine every 4 hours according to the VAS score. The primary end-point was the morphine requirements. Secondary end-points were VAS score, side effects, and mortality. RESULTS: Demographic data and surgical procedures were similar between groups. After morphine titration, the VAS pain score did not differ between groups. All patients in-group M received additional morphine. Morphine mean consumption was increased in CF group: 26 mg (5-42) versus P: 8 mg (3-12) (p=0.0001) or M: 19 mg (8-33) (p<0.006) while constipation was decreased in P group vs CF. Percentage of patients requiring no morphine was similar between P (n=6; 28%) and CF (n=6; 28%) and greater than M (n=0; 0%). Hospital discharge, cardiovascular or pulmonary complications and mortality after 6 months showed no statistical difference. CONCLUSION:Continuous femoral nerve block provided limited pain relief after hip fracture did not reduced side effects and induced an expensive cost.
Authors: Opinder Sahota; Martin Rowlands; Jim Bradley; Gerrie Van de Walt; Nigel Bedforth; Sarah Armstrong; Iain Moppett Journal: Trials Date: 2014-05-24 Impact factor: 2.279
Authors: William D Harrison; Deborah Lees; Jamie A'Court; Thomas Ankers; Ian Harper; Dominic Inman; Mike R Reed Journal: Surg Res Pract Date: 2015-11-16
Authors: Martin Rowlands; Gerrie van de Walt; Jim Bradley; Alexa Mannings; Sarah Armstrong; Nigel Bedforth; Iain K Moppett; Opinder Sahota Journal: BMJ Open Date: 2018-04-10 Impact factor: 2.692
Authors: Fernando R Altermatt; Ghislaine C Echevarría; René F de la Fuente; Ricardo Baeza; Marcela Ferrada; Juan C de la Cuadra; Marcia A Corvetto Journal: Braz J Anesthesiol Date: 2018-07-17